Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 1, 2009, Pages 43-51

  Park, Young Kyoung ^a   Jung, Sook In ^b   Park, Kyong Hwa ^b   Cheong, Hae Suk ^a   Peck, Kyong Ran ^a   Song, Jae Hoon ^a,c   Ko, Kwan Soo ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

Acinetobacter; Colistin resistance; Multilocus sequence typing (MLST)

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ACINETOBACTER BAUMANNII; ACINETOBACTER BAUMANNII SUBGROUP A; ACINETOBACTER BAUMANNII SUBGROUP B; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; CLONING; GENE CLUSTER; GENE LOCUS; GENOME; HOSPITAL; ISOLATION PROCEDURE; KOREA; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; ACINETOBACTER; ACINETOBACTER INFECTION; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA SEQUENCE; DRUG EFFECT; EPIDEMIOLOGY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; COLISTIN; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; KOREA; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 65649151735     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.01.012     Document Type: Article

References (25)

1. Bartual S.G., Seifert H., Hippler C., Luzon M.A.D., Wisplinghoff H., and Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43 (2005) 4382-4390
2. Bonomo R.A., and Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43 Suppl 2 (2006) S49-S56
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Document M100-S17 (2007), CLSI, Wayne, Pa
4. Falagas M.W., and Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40 (2005) 1333-1341
5. Feil E.J., and Spratt B.G. Recombination and the population structures of bacterial pathogens. Annu. Rev. Microbiol. 55 (2001) 561-590
6. Gales A.C., Jones R.N., and Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin. Microbiol. Infect. 12 (2006) 315-321
7. Gardam M.A., Burrows L.L., Kus J.V., Brunton J., Low D.E., Conly J.M., and Humar A. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak?. J. Infect. Dis. 186 (2002) 1754-1760
8. Gatzeva-Topalova P., May A.P., and Sousa M.C. Crystal structure and mechanism of the Escherichia coli ArnA (PmrI) transformylase domain. An enzyme for lipid A modification with 4-amino-4-deoxy-l-arabinose and polymyxin resistance. Biochemistry 44 (2005) 5328-5338
9. Gilad J., Eskira S., Riesenberg K., Schlaeff er F., Hyam E., and Borer A. Emergence of nosocomial colistin-resistant Acinetobacter baumannii. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; Washington, DC, USA; Dec 16-19 (2005)
10. Hawley J.S., Murray C.K., and Jorgensen J.H. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob. Agents Chemother. 52 (2008) 351-352
11. Higgins P.G., Wisplinghoff H., Krut O., and Seifert H. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin. Microbiol. Infect. 13 (2007) 1199-1201
12. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., Chung D.R., Peck K.R., and Song J.H. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60 (2007) 1163-1167
13. La Scola B., Gundi V.A.K.B., Khamis A., and Raout D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44 (2006) 827-832
14. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., and Liolios L. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50 (2006) 2946-2950
15. Li J., Nation R.L., Turnidge J.D., Milne R.W., Coulthard K., Rayner C.R., and Paterson D.L. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6 (2006) 589-601
16. Maiden M.C.J. Multilocus sequence tying of bacteria. Annu. Rev. Microbiol. 60 (2006) 561-588
17. Metzgar D., Bacher J.M., Pezo V., Reader J., Doring V., Schimmel P., Marliere P., and de Crecy-Lagard V. Acinetobacter sp. ADP1: an ideal model organism for genetic analysis and genome engineering. Nucleic Acids Res. 32 (2004) 5780-5790
18. Nemec A., Krizova L., Maixnerova M., Diancourt L., van der Reijden T.J., Brisse S., van den Broek P., and Dijkshoorn L. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J. Antimicrob. Chemother. 62 (2008) 484-489
19. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., and Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51 (2007) 3471-3484
20. Shelburne S.A., Singh K.V., White A.C., Byrne L., Carmer A., Austin C., Graviss E., Stager C., Murray B.E., and Atmar R.L. Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J. Clin. Microbiol. 46 (2008) 198-205
21. Tan C.H., Li J., and Nation R.L. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob. Agents Chemother. 51 (2007) 3413-3415
22. Towner K.J., Levi K., Vlassiadi M., and on behalf of the ARPAC Steering Group. Genetic diversity of carbapenems-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 14 (2008) 161-167
23. Vallenet D., Nordmann P., Barbe V., Poirel L., Mangenot S., Bataille E., Dossat C., Gas S., Kreimeyer A., Lenoble P., Oztas S., Poulain J., Segurens B., Robert C., Abergel C., Claverie J.M., Raoult D., Medigue C., Weissenbach J., and Cruveiller S. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS. One. 3 (2008) e105
24. van Dessel H., Dijkshoorn L., van der Reijden T., Bakker N., Paauw A., van den Broek P., and Brisse S. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 155 (2004) 105-112
25. Wisplinghoff H., Hippler C., Bartual S.G., Haefs C., Stefanik D., Higgins P.G., and Seifert H. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin. Microbiol. Infect. 14 (2008) 708-715